Article info

Download PDFPDF

Extended report
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study

Authors

  1. Correspondence to Professor Jürgen Braun, Department of Rheumatology, Rheumazentrum Ruhrgebiet, Claudiusstr. 45, Herne 44649, Germany; j.braun{at}rheumazentrumruhrgebiet.de
View Full Text

Citation

Braun J, Baraliakos X, Deodhar A for the MEASURE 1 study group, et al
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study

Publication history

  • Received April 18, 2016
  • Revised November 18, 2016
  • Accepted November 20, 2016
  • First published December 13, 2016.
Online issue publication 
May 13, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.